Eam Investors, LLC Neogenomics Inc Transaction History

Eam Investors, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $1.17 Million - $1.65 Million	-83,117 Reduced 64.45%	45,855 $736,000
Q1 2023 Jul 12, 2023	BUY	$9.09 - $19.45 $984,410 - $2.11 Million	108,296 Added 523.78%	128,972 $2.25 Million
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $187,944 - $402,148	20,676 New	20,676 $359,000
Q1 2021 May 11, 2021	SELL	$41.56 - $59.88 $2.11 Million - $3.03 Million	-50,671 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$36.08 - $56.47 $1.83 Million - $2.86 Million	50,671 New	50,671 $2.73 Million
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $1.83 Million - $2.35 Million	-75,705 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$20.5 - $34.53 $178,452 - $300,583	8,705 Added 12.99%	75,705 $2.09 Million
Q4 2019 Feb 11, 2020	BUY	$18.96 - $29.84 $1.27 Million - $2 Million	67,000 New	67,000 $1.96 Million
Q3 2019 Nov 13, 2019	SELL	$19.12 - $26.24 $3.16 Million - $4.33 Million	-165,058 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $349,344 - $430,209	-17,851 Reduced 9.76%	165,058 $3.62 Million
Q1 2019 May 13, 2019	SELL	$12.14 - $20.46 $128,951 - $217,326	-10,622 Reduced 5.49%	182,909 $3.74 Million
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $1.2 Million - $1.97 Million	106,424 Added 122.18%	193,531 $2.44 Million
Q2 2018 Aug 03, 2018	BUY	$7.99 - $14.05 $695,984 - $1.22 Million	87,107 New	87,107 $1.14 Million
Q4 2017 Feb 12, 2018	SELL	$8.02 - $11.18 $1.93 Million - $2.7 Million	-241,059 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$9.11 - $11.26 $2.2 Million - $2.71 Million	241,059	241,059 $2.68 Million

296

125M

698K

116K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.7B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.